News Highlights: Top Company News of the Day
January 21 2021 - 5:15PM
Dow Jones News
IBM Pledges to Return to Growth in 2021
International Business Machines expects to return to revenue
growth this year, even as corporate customers' focus on preserving
cash during the coronavirus pandemic drove a 4.6% revenue decline
in 2020.
Federal Judge Denies Parler's Bid to Force Amazon to Resume Service
The judge ruled that Parler's claims didn't meet the threshold
for a preliminary injunction, though the court wasn't yet
dismissing the company's claims against Amazon.
Intel Caps Off Difficult Year With Record Sales
The chip maker reported a slight drop in earnings for 2020, but
sales hit a record high of $77.9 billion. The company also boosted
its dividend.
Fidelity Personal-Investing President Kathleen Murphy to Retire in 2021
For more than a dozen years, she led a business that now
oversees $3.6 trillion in assets.
Corteva Faces Renewed Activist Pressure
The crop seed and pesticide maker is confronting pressure from
Starboard Value, less than two years after the agriculture company
launched.
Maersk Ship Loses 750 Containers Overboard in Pacific Ocean
Rough seas during a trip from China to Los Angeles caused the
loss, the latest in a series of weather-related accidents at sea
affecting millions of dollars in cargo.
Ford, GM Stocks Rally on Electric-Vehicle Enthusiasm
Until lately, Detroit's auto makers haven't benefited much from
Wall Street's fixation with electric and driverless cars, but
shares of both Ford and GM are both up about 35% so far this
month.
Facebook Refers Trump Suspension to Oversight Board
The social-media company said a decision from its independent
panel on the matter-the biggest issue it has tackled since being
set up last year-would be binding.
Britain's IG Group to Buy U.S. Options Firm Tastytrade for $1 Billion
The deal, which would substantially increase IG's presence in
the U.S. market. is a bid to capitalize on the boom in options
trading by small investors.
Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds
The drugmaker plans to ask U.S. health regulators to expand
bamlanivimab's use to protect nursing-home residents and staff from
Covid-19.
(END) Dow Jones Newswires
January 21, 2021 17:00 ET (22:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.